Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Predictmedix AI Inc PMEDF


Primary Symbol: C.PMED

Predictmedix AI Inc. is a life sciences technology company. The Company, through its subsidiaries, focuses on artificial intelligence (AI) technologies which target two specific areas: workplace health and safety and healthcare. It has developed a technology for the identification and detection of infectious disease symptoms, including COVID-19, referred to as its infectious disease symptom screening solutions (IDSS) and marketed in North America under the name Safe Entry System. It is also developing AI-powered products that address detection of alcohol and/or cannabis impairment in individuals; mental illness screening, and remote patient monitoring and treatment plans, referred to as the Mobile Wellbeing product. It is adding additional modules to this Mobile Wellbeing platform that enable us to use a patient’s history and real-time medical data, such as blood pressure, and to provide patients and their medical professionals with treatment plans for chronic disease management.


CSE:PMED - Post by User

Comment by badog222on Dec 06, 2020 1:38pm
130 Views
Post# 32046225

RE:To New Investors

RE:To New Investorspatience1....
How do they tap into all these opportunities if they can't even prove the AI tech works?

In January didn't you say that Cult/PMED anticipated trading in the US in February and would simultaneously announce results for their 3,500 person test case?    It's now December…where are the results of the test case?   I once questioned the AI ability to detect anything and I believe you told me that it was already proven that it could detect alcohol use and drug use.   Where is the proof of that? 

Their disclaimer states...   "The Company is not making any express or implied claims that its product has the ability to diagnose, eliminate, cure or contain the Covid-19 (or SARS-2 Coronavirus) at this time."
 Definition of diagnose
Diagnose | Definition of Diagnose by Merriam-Webster
1a:      to recognize (something, such as a disease) by signs and symptoms
Isn't recognizing by signs and symptoms the objective?   Via various scanning methods?   Includes Covid, alcohol use, drug use, etc.  But are there no claims the AI can do that?

 
If the test case results were good why would they hold them back?   I think it's apparent why?

A share price doesn't just run up and down and back up for no reason.  
If the current sp increase was due to an announcement of successful AI test trials I would fully understand the reason.   Where are the test results.   Where are contracts and revenues that would accompany successful test results?    Seems to me that promoters / traders are buying heavy to raise the sp and then selling to bring it back down and then buying again.

We have continually been informed of so-called opportunities.   If PMED doesn't announce successful test/trial results others may be the ones taking advantage of these opportunities.   

Badog


<< Previous
Bullboard Posts
Next >>